Track topics on Twitter Track topics that are important to you
Supply Chain Issues, the Need for Additional Talent Chemists, Lower Drug Prices, Growth of Development in the U.S. Will Be Key Factors
SEQENS North America (formerly PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs), and other specialty chemical products, issued its annual list of trends that will affect the emerging pharmaceutical and generic drug sectors, as well as Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) in 2020.
“The industry will face more chaos in 2020 due to continued pressure to lower drug prices in the U.S., which means that Big Pharma as well as CDMOs need to continue to find ways to work smarter, more effectively to bring down costs that otherwise can exceed $2 billion before a drug is brought to market, based on estimates from Tufts University,” said Ed Price, president of Seqens NA. “We’re also seeing concerns about drug shortages and the need to stockpile some necessary drugs as well as a shortage of qualified chemists in 2020.”
Below are four trends that Seqens NA expects will impact the industry this year:
About SEQENS North America
Seqens North America (formerly PCI Synthesis) is a Pharmaceutical Development CDMO (Contract Development and Manufacturing Organization) based in Newburyport, Mass., a division of Seqens, an integrated global leader in pharmaceutical synthesis and specialty ingredients with 24 manufacturing sites and 3 R&D centers in Europe, North America and Asia.
Seqens North America is also a commercial manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products for the medical device industry. As a CDMO, Seqens North America provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules. To learn more about SEQENS North America, its proprietary NCE development activities and process R&D capabilities please visit www.seqens.com.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...